Literature DB >> 21492205

Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells.

Y Kasashima1, T Ueno, A Tomita, A E Goodship, R K W Smith.   

Abstract

REASONS FOR PERFORMING STUDY: Mesenchymal stem cell (MSC) therapy for orthopaedic disease is being used with increasing frequency; there is a need to define a safe, reliable and effective technique for the recovery of MSCs from the sternum of the horse.
OBJECTIVES: To describe an optimised safe technique for obtaining bone marrow-derived MSCs from the sternum of the Thoroughbred horse.
METHODS: The anatomical relationship of the sternum with the heart and internal anatomy was demonstrated in cadavers. Sternal anatomy was evaluated ultrasonographically and after midline sectioning. Sternebrae were examined histologically after aspiration to determine the effect of needle insertion. The quality of the aspirate was evaluated as the number of colony-forming units from sequential and separately aspirated 5 ml aliquots and assessed for their multipotency using trilineage differentiation.
RESULTS: The optimal safe location for the needle was the 5th sternebra because it had a safe dorsoventral thickness and was cranial to the apex of the heart. This sternebra could be reliably identified ultrasonographically. Aspirates could also be obtained from the 4th and 6th sternebrae, although the former is between the front limbs and the latter closer to the heart. Minimal disruption of the internal bony architecture was seen after needle insertion through the thin outer cortex and the first 5 ml aliquot contained the greatest number of colony-forming units of mesenchymal stem cells with trilineage capabilities.
CONCLUSIONS: Accurate placement of a Jamshidi needle into the medullary cavity of the 4th-6th individual sternebrae is facilitated by the use of ultrasonography and enables aspiration of bone marrow reliably with minimal damage to the sternum and risk to the horse. POTENTIAL CLINICAL RELEVANCE: Sternal marrow aspiration as described is a safe and reliable technique to obtain MSCs for orthopaedic cell-based therapies.
© 2010 EVJ Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21492205     DOI: 10.1111/j.2042-3306.2010.00215.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  17 in total

1.  Equine bone marrow-derived mesenchymal stromal cells (BMDMSCs) from the ilium and sternum: are there differences?

Authors:  M K Adams; L R Goodrich; S Rao; F Olea-Popelka; N Phillips; J D Kisiday; C W McIlwraith
Journal:  Equine Vet J       Date:  2012-09-26       Impact factor: 2.888

2.  In Vivo Imaging and Tracking of Technetium-99m Labeled Bone Marrow Mesenchymal Stem Cells in Equine Tendinopathy.

Authors:  Jayesh Dudhia; Patricia Becerra; Miguel A Valdés; Francisco Neves; Neil G Hartman; Roger K W Smith
Journal:  J Vis Exp       Date:  2015-12-09       Impact factor: 1.355

3.  A comparison of three-dimensional culture systems to evaluate in vitro chondrogenesis of equine bone marrow-derived mesenchymal stem cells.

Authors:  Ashlee E Watts; Jeremy C Ackerman-Yost; Alan J Nixon
Journal:  Tissue Eng Part A       Date:  2013-07-24       Impact factor: 3.845

Review 4.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

5.  Population doubling level-dependent change of secreted glycosaminoglycan in equine bone marrow-derived mesenchymal stem cells.

Authors:  Takafumi Sasao; Yuki Fukuda; Sayako Yoshida; Shihori Miyabara; Yoshinori Kasashima; Atsutoshi Kuwano; Katsuhiko Arai
Journal:  J Equine Sci       Date:  2015-09-30

6.  Differentiation of equine mesenchymal stromal cells into cells of neural lineage: potential for clinical applications.

Authors:  Claudia Cruz Villagrán; Lisa Amelse; Nancy Neilsen; John Dunlap; Madhu Dhar
Journal:  Stem Cells Int       Date:  2014-11-24       Impact factor: 5.443

7.  Biopsy Needle Advancement during Bone Marrow Aspiration Increases Mesenchymal Stem Cell Concentration.

Authors:  Anne E Peters; Ashlee E Watts
Journal:  Front Vet Sci       Date:  2016-03-14

8.  Regulation of Tenomodulin Expression Via Wnt/β-catenin Signaling in Equine Bone Marrow-derived Mesenchymal Stem Cells.

Authors:  Shihori Miyabara; Yohei Yuda; Yoshinori Kasashima; Atsutoshi Kuwano; Katsuhiko Arai
Journal:  J Equine Sci       Date:  2014-04-22

9.  Isolation of equine multipotent mesenchymal stromal cells by enzymatic tissue digestion or explant technique: comparison of cellular properties.

Authors:  Claudia Gittel; Walter Brehm; Janina Burk; Henriette Juelke; Carsten Staszyk; Iris Ribitsch
Journal:  BMC Vet Res       Date:  2013-10-29       Impact factor: 2.741

10.  Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.

Authors:  N Ardanaz; F J Vázquez; A Romero; A R Remacha; L Barrachina; A Sanz; B Ranera; A Vitoria; J Albareda; M Prades; P Zaragoza; I Martín-Burriel; C Rodellar
Journal:  BMC Vet Res       Date:  2016-03-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.